Literature DB >> 19181778

The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells.

Brigitte Mohr, Uta Oelschlaegel, Christian Thiede, Michelle Meredyth Stewart, Gerhard Ehninger, Uwe Platzbecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19181778      PMCID： PMC2649340          DOI： 10.3324/haematol.13865

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  5 in total

1.  Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation.

Authors:  J Mattsson; M Uzunel; L Tammik; J Aschan; O Ringdén
Journal:  Leukemia       Date:  2001-12       Impact factor: 11.528

2.  Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis.

Authors:  Mario Cazzola
Journal:  Haematologica       Date:  2008-07       Impact factor: 9.941

3.  Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Authors:  Alan List; Gordon Dewald; John Bennett; Aristotle Giagounidis; Azra Raza; Eric Feldman; Bayard Powell; Peter Greenberg; Deborah Thomas; Richard Stone; Craig Reeder; Kenton Wride; John Patin; Michele Schmidt; Jerome Zeldis; Robert Knight
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

4.  Efficacy of lenalidomide in myelodysplastic syndromes.

Authors:  Alan List; Sandy Kurtin; Denise J Roe; Andrew Buresh; Daruka Mahadevan; Deborah Fuchs; Lisa Rimsza; Ruth Heaton; Robert Knight; Jerome B Zeldis
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

5.  Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.

Authors:  Ch Thiede; K Lutterbeck; U Oelschlägel; M Kiehl; Ch Steudel; U Platzbecker; C Brendel; A A Fauser; A Neubauer; G Ehninger; M Bornhäuser
Journal:  Ann Hematol       Date:  2002       Impact factor: 3.673
  5 in total
  1 in total

1.  Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell study.

Authors:  Laurent Garderet; Ladan Kobari; Christelle Mazurier; Caroline De Witte; Marie-Catherine Giarratana; Christine Pérot; Norbert Claude Gorin; Hélène Lapillonne; Luc Douay
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.